148 related articles for article (PubMed ID: 26014594)
1. The FDA and genetic testing.
Litwack ED; Mansfield E; Shuren J
N Engl J Med; 2015 Jun; 372(23):2273-4. PubMed ID: 26014594
[No Abstract] [Full Text] [Related]
2. The FDA and genomic tests--getting regulation right.
Evans BJ; Burke W; Jarvik GP
N Engl J Med; 2015 Jun; 372(23):2258-64. PubMed ID: 26014592
[No Abstract] [Full Text] [Related]
3. In search of a coherent framework: options for FDA oversight of genetic tests.
Javitt GH
Food Drug Law J; 2007; 62(4):617-52. PubMed ID: 18557224
[No Abstract] [Full Text] [Related]
4. Regulating genetic tests: issues that guide policy decisions.
Horn EJ; Terry SF
Genet Test Mol Biomarkers; 2012 Jan; 16(1):1-2. PubMed ID: 22276932
[No Abstract] [Full Text] [Related]
5. Policy implications of genetic testing: not just for geneticists anymore.
Javitt GH
Adv Chronic Kidney Dis; 2006 Apr; 13(2):178-82. PubMed ID: 16580620
[TBL] [Abstract][Full Text] [Related]
6. Genetic testing and FDA regulation: overregulation threatens the emergence of genomic medicine.
Evans JP; Watson MS
JAMA; 2015 Feb; 313(7):669-70. PubMed ID: 25560537
[No Abstract] [Full Text] [Related]
7. Pharmacogenetics and ethical considerations: why care?
Marx-Stölting L
Pharmacogenomics J; 2007 Oct; 7(5):293-6. PubMed ID: 17033614
[No Abstract] [Full Text] [Related]
8. Standards and controls for genetic testing.
Winn-Deen ES
Cancer Biomark; 2005; 1(4-5):217-20. PubMed ID: 17192044
[TBL] [Abstract][Full Text] [Related]
9. The incorporation of new technologies into genetic services; the importance of government support.
Holtzman NA
Birth Defects Orig Artic Ser; 1992; 28(3):126-30. PubMed ID: 1489950
[No Abstract] [Full Text] [Related]
10. Molecular medicine: how, what, and when?
Woodcock J
Clin Pharmacol Ther; 2007 Oct; 82(4):376-8. PubMed ID: 17851578
[TBL] [Abstract][Full Text] [Related]
11. 23andMe and the FDA.
Annas GJ; Elias S
N Engl J Med; 2014 Mar; 370(11):985-8. PubMed ID: 24520936
[No Abstract] [Full Text] [Related]
12. Tumour tissue: who is in control?
Ploem MC; Retèl VP; Linn SC; van Boven HH; Schmidt MK; de Jong JP; Gevers JK; van Harten WH
Lancet Oncol; 2010 Jan; 11(1):9-11. PubMed ID: 19880349
[No Abstract] [Full Text] [Related]
13. A measure of truth in genetic testing.
Zonno KD; Terry PF; Terry SF
Genet Test Mol Biomarkers; 2009 Jun; 13(3):285-6. PubMed ID: 19473075
[No Abstract] [Full Text] [Related]
14. Innovation, risk, and patient empowerment: the FDA-mandated withdrawal of 23andMe's Personal Genome Service.
Downing NS; Ross JS
JAMA; 2014 Feb; 311(8):793-4. PubMed ID: 24474248
[No Abstract] [Full Text] [Related]
15. FDA moves to regulate thousands of diagnostic tests.
Caffrey MK
Am J Manag Care; 2014 Aug; 20(11 Spec No.):E12. PubMed ID: 25618155
[No Abstract] [Full Text] [Related]
16. Panel softens cancer gene test warning.
Wadman M
Nature; 1996 Apr; 380(6575):573. PubMed ID: 8602252
[No Abstract] [Full Text] [Related]
17. Preimplantation diagnosis for genetic susceptibility.
Gibbons WE
N Engl J Med; 2006 Nov; 355(19):2048. PubMed ID: 17093261
[No Abstract] [Full Text] [Related]
18. The need for increased oversight of genetic testing: a detailed look at the genetic testing process.
Bonnin DC
Houst J Health Law Policy; 2003; 4(1):149-80. PubMed ID: 16596751
[No Abstract] [Full Text] [Related]
19. Genetic testing and discrimination: how private is your information?
Slaughter LM
Stanford Law Pol Rev; 2006; 17(1):67-81. PubMed ID: 17165231
[No Abstract] [Full Text] [Related]
20. Genetic disability: a modest proposal to modify the ADA to protect against some forms of genetic discrimination.
Chorpening J
North Carol Law Rev; 2004 May; 82(4):1441-81. PubMed ID: 16437812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
